semaglutide 2 mg/ml Flex-Dose mL Injectable 2.5 Ozempic 2 mg/1.5 mL (1.34

Radkowski MJ, Sawiski P, Targowski T

JX: Data curation, Funding acquisition, Writing review & editing

Nausea and GI Tolerability: Managing Dual Symptoms Semaglutide-related nausea affects 2540% of patients at therapeutic doses and often peaks in the first 48 weeks

Another group described increased CSF levels of total homocysteine but normal ones of free homocysteine in PD patients (Isobe et al., 2005), with an additional increase after treatment with levodopa, while total methionine levels decreased after this therapy (Isobe et al., 2010a)

101 It is essential to examine the cardiovascular profile of GLP-1 analogs as well since DPP4 inhibitors increase GLP-1 levels